• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Delivering Better Gut Health Supplements

    Delivering Dietary Supplements that Exceed Consumer Expectations

    Green Business Network Seeks Comment on New Certification for Hemp-CBD Businesses

    Sweeteners Market Continues to Broaden with Cleaner Labels and Better Formulations

    Optimizing Gut Health: Unlocking the Gates to Well-Being
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health

    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status

    Nutritional Complex Evidenced to Reduce Preterm Birth

    Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass in Older Adults

    AHPA’s 9th Botanical Congress to Take Place May 24
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health

    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status

    Nutritional Complex Evidenced to Reduce Preterm Birth

    Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass in Older Adults

    AHPA’s 9th Botanical Congress to Take Place May 24
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health

    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status

    Nutritional Complex Evidenced to Reduce Preterm Birth

    Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass in Older Adults

    AHPA’s 9th Botanical Congress to Take Place May 24
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health

    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status

    Nutritional Complex Evidenced to Reduce Preterm Birth

    Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass in Older Adults

    First Day Life Shuts Down Children's Behavioral, Cognitive Health Claims Following Challenge
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Gencor

    Aiya America (Matcha by Aiya)

    Sabinsa Corporation

    Bioenergy Life Science, Inc. (BLS)

    Chenland Nutritionals Inc.
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Vesta Nutra

    Gencor

    Aiya America (Matcha by Aiya)

    Nutrition21, LLC

    Chenland Nutritionals Inc.
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Federal Agencies Warn Company Marketing Unapproved CBD Products

    ‘These actions should send a message to the broader market about complying with FDA requirements,’ says Acting FDA Commissioner.

    Federal Agencies Warn Company Marketing Unapproved CBD Products
    Related CONTENT
    • Sunflower Hemp Co
    • CBD in the Clinic: How Practitioners View Life After the Farm Bill
    • The CBD Craze: Still Only the Beginning
    • Cannovia: Clearing Up CBD Market Confusion
    • Resveratrol: The Healthy Aging Nutrient
    10.22.19
    The U.S. Food and Drug Administration and the Federal Trade Commission posted a joint warning letter to Rooted Apothecary LLC, of Naples, FL, for illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat teething pain and ear aches in infants, autism, attention-deficit/hyperactivity disorder (ADHD), as well as Parkinson’s and Alzheimer’s disease, among other conditions or diseases.
     
    “Cannabis and cannabis-derived compounds are subject to the same laws and requirements as FDA-regulated products that contain any other substance. We are working to protect Americans from companies marketing products with unsubstantiated claims that they prevent, diagnose, treat, or cure a number of diseases or conditions,” said Acting FDA Commissioner Ned Sharpless, MD.
     
    “This is especially concerning when companies are peddling unproven CBD products for use in vulnerable populations like infants and children,” he continued. “We’ve sent numerous warning letters that focus on matters of significant public health concern to CBD companies, and these actions should send a message to the broader market about complying with FDA requirements. As we examine potential regulatory pathways for the lawful marketing of cannabis products, protecting and promoting public health through sound, science-based decision-making remains our top priority. We appreciate the FTC joining us on these and other actions to protect consumers from fraudulent CBD products.”
     
    As described in the warning letter issued to Rooted Apothecary, the company used product webpages, through its online store and social media websites, to make unfounded claims about its CBD products, and some of the products were also unlawfully marketed as dietary supplements. The agency has determined that CBD products cannot be marketed as dietary supplements.
     
    Examples of the unsupported claims made by the company include:
     
    “Instead of synthetic chemical[s] that can have safety concerns, this blend uses the best of nature to help calm the inflammation and pain of teething, while also promoting sleepiness for your little one.”
     
    “No matter what age, ear aches are a terrible, no good way to live each day! Our main priority was safety, effectiveness ... as we formulated this for the entire family including our precious little ones. When the pain is bad, this roller goes to work for soothing pain, inflammation, and to battle against the bacterial/viral critters to blame.”
     
    “Increasing evidence suggests that CBD oil is a powerful option for pain ... anxiety ... and autism ... It seems like an attractive and safe option for children.”
     
    “CBD oil may have neuroprotective properties and may protect against neurological conditions, such as Parkinson’s and Alzheimer’s disease.”
     
    “[P]ossible uses for CBD include helping with skin problems such as acne, autism, ADHD, and even cancer. It’s often used in conjunction with traditional treatments to provide extra help. Children can use high amounts of CBD safely and without any risk.”
     
    Additionally, under the Federal Trade Commission Act, it is unlawful to advertise that a product can prevent, treat, or cure human disease unless the advertiser possesses competent and reliable scientific evidence, including, when appropriate, well-controlled human clinical studies, substantiating that the claims are true at the time they are made.
     
    More generally, to make or exaggerate such claims, whether directly or indirectly, through the use of a product name, website name, metatags, or other means, without rigorous scientific evidence sufficient to substantiate the claims, violates the FTC Act. The FTC is concerned that one or more of the efficacy claims cited may not be substantiated by competent and reliable scientific evidence.
     
    These products are also misbranded under the Federal Food, Drug, and Cosmetic (FD&C) Act, because the products’ labels and product information fail to include adequate directions for use. Drugs in the U.S. must contain directions explaining how a consumer can use a drug safely for its intended purpose. Under the law, there is an exemption for this labeling requirement for prescription drugs that have FDA-approved applications in effect. However, none of Rooted Apothecary’s products are FDA-approved.
     
    The FDA and FTC have requested responses from Rooted Apothecary within 15 working days stating how the company will correct the violations. Failure to correct the violations promptly may result in legal action, including product seizure and/or injunction. Violations of the FTC Act may result in legal action seeking a Federal District Court injunction or administrative cease and desist order, and an order also may require that a company pay back money to consumers.
     
    The FDA continues to be concerned about the proliferation of products claiming to contain CBD that are marketed for therapeutic or medical uses that have not been approved by the agency. The FDA approval process ensures that drugs on the market are safe and effective for their intended therapeutic uses.
     
    CBD is marketed in a variety of product types, such as oil drops, capsules, syrups, teas and topical lotions and creams. The FDA has not approved any CBD products other than one prescription human drug product to treat rare, severe forms of epilepsy. There is very limited information for other marketed CBD products, which likely differ in composition from the FDA-approved product and have not been evaluated for potential adverse effects on the body.
     
    The FDA continues to explore potential pathways for various types of CBD products to be lawfully marketed. An important component of this work is obtaining and evaluating information to address outstanding questions related to the safety of CBD products while maintaining the FDA’s rigorous public health standards.
     
    “The FDA is working quickly to further clarify our regulatory approach for products containing cannabis and cannabis-derived compounds like CBD while using all available resources to monitor the marketplace and protect public health by taking action as needed against companies,” said FDA Principal Deputy Commissioner Amy Abernethy, MD, PhD. “We recognize that there is significant public interest in cannabis and cannabis-derived compounds; however, we must work together to fill in the knowledge gaps about the science, safety and quality of many of these products. We are committed to advancing our regulation of these products through an approach that, in line with our mission, prioritizes public health, fosters innovation and promotes consumer confidence.”
     
    Unlike drugs approved by the FDA, the manufacturing process of unapproved CBD products has not been subject to FDA review as part of the drug approval process. Further, there has been no FDA evaluation of whether these products are effective for their intended use, what the proper dosage is, how they could interact with FDA-approved drugs, or whether they have dangerous side effects or other safety concerns. Consumers may put off getting important medical care, such as proper diagnosis, treatment and supportive care due to unsubstantiated claims associated with CBD products. For that reason, it’s important that consumers talk to a health care professional about the best way to treat diseases or conditions with existing, approved treatment options.
     
    The FDA has previously sent warning letters to other companies illegally selling CBD products that claimed to prevent, diagnose, treat or cure serious diseases, such as cancer. Some of these products were in further violation of the FD&C Act because they were marketed as dietary supplements or because they involved the addition of CBD to food.
     
    The FDA encourages healthcare professionals and consumers to report adverse reactions associated with these or similar products to the agency’s MedWatch program.
    Related Searches
    • Dosage
    • Cancer
    • ADHD
    • Regulation
    Related Knowledge Center
    • Herbs & Botanicals
    • Regulations
    Suggested For You
    Sunflower Hemp Co Sunflower Hemp Co
    CBD in the Clinic: How Practitioners View Life After the Farm Bill CBD in the Clinic: How Practitioners View Life After the Farm Bill
    The CBD Craze: Still Only the Beginning The CBD Craze: Still Only the Beginning
    Cannovia: Clearing Up CBD Market Confusion Cannovia: Clearing Up CBD Market Confusion
    Resveratrol: The Healthy Aging Nutrient Resveratrol: The Healthy Aging Nutrient
    FDA Approves Impossible Foods Petition, Allows Soy Leghemoglobin as Color Additive FDA Approves Impossible Foods Petition, Allows Soy Leghemoglobin as Color Additive
    Industry Calls for Label Literacy of New Supplement Facts Label Industry Calls for Label Literacy of New Supplement Facts Label
    Area Code 420 Has Arrived Area Code 420 Has Arrived
    Charlotte’s Web Introduces Hemp Extract-Infused Gummies Charlotte’s Web Introduces Hemp Extract-Infused Gummies
    FDA Allows Claims for EPA/DHA Omega-3 and Risk of Hypertension & Coronary Heart Disease FDA Allows Claims for EPA/DHA Omega-3 and Risk of Hypertension & Coronary Heart Disease
    Levagen PEA: A Legal Answer to CBD’s Issues Levagen PEA: A Legal Answer to CBD’s Issues
    FDA Warns Women of Childbearing Age to Avoid Vinpocetine FDA Warns Women of Childbearing Age to Avoid Vinpocetine
    Preparing for FDA’s New Era of Food Safety Preparing for FDA’s New Era of Food Safety
    DSHEA Discussion: Assessing Standards for Scientific Evidence DSHEA Discussion: Assessing Standards for Scientific Evidence
    Move Over Mainstream, Healthy Foods Are Here to Stay Move Over Mainstream, Healthy Foods Are Here to Stay

    Related Breaking News

    • Cardiovascular Health | Certifications, Approvals & Patents | Contract Manufacturing | Delivery & Dosage Technologies | Dietary Supplements | Functional Foods & Beverages | Green Foods | Herbs & Botanicals | Natural/Organic | Quality & Safety | Supplier News | Weight Management/Weight Loss | World Markets
      CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status

      CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status

      The coffee extract, formulated for metabolic health benefits, is now primed for the U.S. market.
      Mike Montemarano, Associate Editor 04.09.21

    • Breaking News | Consumer Trends | Contract Manufacturing | Dietary Supplements | Functional Foods & Beverages | Healthcare Trends | Herbs & Botanicals | Industry & Market News | Natural/Organic | Regulations
      AHPA’s 9th Botanical Congress to Take Place May 24

      AHPA’s 9th Botanical Congress to Take Place May 24

      The one-day virtual event will explore the unique challenges related to the pandemic that have directly impacted businesses.
      Mike Montemarano, Associate Editor 04.09.21

    • Cognitive Function | Dietary Supplements | Infant & Children's Health | Quality & Safety | Regulations | Regulatory News | World Markets
      First Day Life Shuts Down Children

      First Day Life Shuts Down Children's Behavioral, Cognitive Health Claims Following Challenge

      Several claims and consumer testimonials claimed that a multivitamin supplement could improve children’s behavioral issues such as hyperactivity and tantrums.
      Mike Montemarano, Associate Editor 04.08.21


    • Breaking News | Consumer Trends | Dietary Supplements | Functional Foods & Beverages | Healthcare Trends | Herbs & Botanicals | Industry & Market News | Research | World Markets
      National Survey Suggests Consumer Knowledge of CBD is Highly Limited

      National Survey Suggests Consumer Knowledge of CBD is Highly Limited

      A great deal of discrepancy between CBD and other cannabis products still exists, even among those who've tried it.
      Mike Montemarano, Associate Editor 04.08.21

    • Antioxidants | Breaking News | Delivery & Dosage Technologies | Dietary Supplements | Functional Foods & Beverages | Herbs & Botanicals | Inflammation | Natural/Organic | Research | Research News | Sports Nutrition
      Pilot Study Suggests Tomato Powder has Superior Exercise Recovery Benefits to Lycopene

      Pilot Study Suggests Tomato Powder has Superior Exercise Recovery Benefits to Lycopene

      Tomatoes have additional micronutrients and bioactive components believed to synergistically boost the benefits tied to the popular carotenoid.
      Mike Montemarano, Associate Editor 04.08.21

    • Dietary Supplements | Herbs & Botanicals | Natural/Organic | People News | Quality & Safety | Regulations | World Markets
      AHPA Hires Glenn Christenson as Director of Communications and Marketing

      AHPA Hires Glenn Christenson as Director of Communications and Marketing

      In his role, Christenson will focus on member communications, media engagement, and promoting AHPA’s educational events.
      Mike Montemarano, Associate Editor 04.07.21


    • Bone & Joint Health | Breaking News | Herbs & Botanicals | Inflammation | Research | Research News | Supplier News
      BCM-95 Curcumin Shown to Improve Serum Inflammatory Markers

      BCM-95 Curcumin Shown to Improve Serum Inflammatory Markers

      New study indicated Arjuna Natural’s proprietary turmeric extract as effective as paracetamol in improving WOMAC scores.
      Sean Moloughney, Editor 04.06.21

    • Breaking News | Probiotics & Prebiotics | Regulations | Regulatory News | Supplier News | World Markets
      Deerland Probiotic DE111 Gains Health Claims Approval in Australia and New Zealand

      Deerland Probiotic DE111 Gains Health Claims Approval in Australia and New Zealand

      Company noted this is the first Bacillus subtilis probiotic to attain food-health relationship claims in the region.
      Sean Moloughney, Editor 04.06.21

    • Breaking News | Herbs & Botanicals | Research | Research News | Supplier Insights | Weight Management/Weight Loss
      Omniactive

      Omniactive's Capsimax Shown to Support Weight Management through Increased Metabolic Rate

      Researchers observed robust and significant changes in resting energy expenditure following supplementation.
      Sean Moloughney, Editor 04.06.21


    • Breaking News | Contract Manufacturing | Dietary Supplements | Functional Foods & Beverages | Industry & Market News | Quality & Safety | Regulations | Research | Testing | World Markets
      CRN, ACI Announce Co-Chairs, Agenda Preview for 9th Annual Forum on Supplements

      CRN, ACI Announce Co-Chairs, Agenda Preview for 9th Annual Forum on Supplements

      Topics on strategies for legal, regulatory, and compliance activity which will be discussed are now available to view online.
      Mike Montemarano, Associate Editor 04.05.21

    • Breaking News | Contract Manufacturing | Dietary Supplements | Fatty Acids | Functional Foods & Beverages | Herbs & Botanicals | Industry & Market News | Natural/Organic | Quality & Safety | Testing | World Markets
      Botanical Adulterants Prevention Program Publishes Olive Oil Lab Doc

      Botanical Adulterants Prevention Program Publishes Olive Oil Lab Doc

      The new publication covers over 90 laboratory analytical methods to authenticate olive oil.
      Mike Montemarano, Associate Editor 03.31.21

    • Breaking News | Cognitive Function | Contract Manufacturing | Functional Foods & Beverages | Green Foods | Herbs & Botanicals | Mood Health & Sleep | Natural/Organic | Products
      Humann Launches New SuperBeets Memory & Focus Chews

      Humann Launches New SuperBeets Memory & Focus Chews

      The polyphenol-rich chews are formulated to promote brain blood flow, support mental alertness, and help to reduce overall stress.
      Mike Montemarano, Associate Editor 03.31.21


    • Antioxidants | Breaking News | Cardiovascular Health | Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Inflammation | Medical Nutrition | Natural/Organic | Research | Research News
      Resveratrol Evidenced to Reduce Markers of Endometriosis Progression in Women

      Resveratrol Evidenced to Reduce Markers of Endometriosis Progression in Women

      Tissue samples from 40 patients showed that reductions in chronic inflammation improved gene expression of endometrial cells.
      Mike Montemarano, Associate Editor 03.26.21

    • Breaking News | Contract Manufacturing | Dietary Supplements | Herbs & Botanicals | Immune Function | Industry & Market News | Natural/Organic | Quality & Safety | Research | Testing | World Markets
      Elder Berry Adulteration Documented By New BAPP Article

      Elder Berry Adulteration Documented By New BAPP Article

      The Botanical Adulterants Prevention Program’s latest installation includes lab data from 532 commercial elderberry samples, evidencing authenticity problems.
      Mike Montemarano, Associate Editor 03.23.21

    • Breaking News | Herbs & Botanicals | Quality & Safety | Research | Research News
      CBD Toxicology Study Affirms Safety, No Liver Issues

      CBD Toxicology Study Affirms Safety, No Liver Issues

      Investigators reported to FDA no evidence of liver toxicity in the 839 adults consuming oral CBD.
      Sean Moloughney, Editor 03.23.21

    Trending
    • NSF/Harvard Study Finds Deterenol, Other Stimulants In Sports & Weight Loss Supplements
    • Several Studies Evaluate Role Of Vitamin D In COVID-19 Outcomes
    • Study Investigates Probiotics Impact On COVID-19 Remission Rates
    • Focus, Endurance, Resilience: The Esports Community Is Seeking Out Supplements
    • New Study Confirms Vegan Vitamin D3 Ingredient Is Bioavailable
    Breaking News
    • Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    • CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    • Nutritional Complex Evidenced to Reduce Preterm Birth
    • Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass in Older Adults
    • AHPA’s 9th Botanical Congress to Take Place May 24
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Optimizing Gut Health: Unlocking the Gates to Well-Being
    • Sweeteners Market Continues to Broaden with Cleaner Labels and Better Formulations
    • Green Business Network Seeks Comment on New Certification for Hemp-CBD Businesses
    • Delivering Dietary Supplements that Exceed Consumer Expectations
    • Delivering Better Gut Health Supplements
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    Nutritional Complex Evidenced to Reduce Preterm Birth
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies to Sponsor and Exhibit at the North American Pultrusion Conference 2021
    Barentz Expands Canadian CASE Team
    Shepherd Color Company Opens Sales Office in China
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Resonetics Leases New Manufacturing Space in Costa Rica
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Ascendia Pharmaceuticals Poised for Expansion
    Bora Pharmaceuticals Adds Roller Compaction Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revlon Unveils New Fragrances Featuring Megan Thee Stallion & Sofia Carson
    Henkel Management Board Welcomes Wolfgang König
    Mielle Organics Gets a Major Investment
    Happi

    Latest Breaking News From Happi

    Nature’s Beauty Debuts Vegan Natural Body Care at Walgreens
    Estée Lauder Expands Beautiful Fragrance Collection
    The Honest Company Files for IPO
    Ink World

    Latest Breaking News From Ink World

    SE-DA Invests in Kornit Presto S
    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Dantex elevates Joseph Sanchez to digital business development manager
    Mactac's Kevin Clunie joins TLMI panel
    MacDermid announces two new global sales roles
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Precision Textiles Offers Biodegradable Medical Fabric
    Northshore Launches Megamax Briefs in New Colors
    Essity Acquires Distribution Rights to Sorbact in Australia and New Zealand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Google Executive Joins SeaSpine's Board of Directors
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Tive Multi-sensor Tracker Solo 5G Relies on Sensirion SHT33
    VTT in 2020: Successful Year Despite Globally Challenging Times
    Lux Research: 3D Printing Market to Reach $51 Billion in 2030

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login